Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.
J Biol Chem. 2011 Jun 17;286(24):21023-32. doi: 10.1074/jbc.X111.258020. Epub 2011 May 4.
Scientific styles vary tremendously. For me, research is largely about the unfettered pursuit of novel ideas and experiments that can test multiple ideas in a day, not a year, an approach that I learned from my mentor Julius "Julie" Axelrod. This focus on creative conceptualizations has been my métier since working in the summers during medical school at the National Institutes of Health, during my two years in the Axelrod laboratory, and throughout my forty-five years at Johns Hopkins University School of Medicine. Equally important has been the "high" that emerges from brainstorming with my students. Nothing can compare with the eureka moments when, together, we sense new insights and, better yet, when high-risk, high-payoff experiments succeed. Although I have studied many different questions over the years, a common theme emerges: simple biochemical approaches to understanding molecular messengers, usually small molecules. Equally important has been identifying, purifying, and cloning the messengers' relevant biosynthetic, degradative, or target proteins, at all times seeking potential therapeutic relevance in the form of drugs. In the interests of brevity, this Reflections article is highly selective, and, with a few exceptions, literature citations are only of findings of our laboratory that illustrate notable themes.
科学风格差异极大。对我来说,研究主要是不受束缚地追求新颖的想法和实验,这些想法和实验可以在一天内而不是一年内检验多个想法,这种方法是我从导师朱利叶斯(“朱莉”)·阿克塞尔罗德那里学到的。自从在医学院暑期在国立卫生研究院工作以来,自从在阿克塞尔罗德实验室的两年,以及在约翰霍普金斯大学医学院的 45 年以来,我一直专注于创造性的概念化。同样重要的是,与我的学生一起进行头脑风暴所带来的“灵感”。没有什么能与与学生一起产生新见解的“顿悟”时刻相比,更妙的是,当高风险、高回报的实验取得成功时。虽然多年来我研究了许多不同的问题,但一个共同的主题出现了:用简单的生化方法来理解分子信使,通常是小分子。同样重要的是确定、纯化和克隆信使的相关生物合成、降解或靶蛋白,始终以药物的形式寻找潜在的治疗相关性。为了简洁起见,这篇反思文章是高度选择性的,除了少数例外,文献引用仅为说明显著主题的我们实验室的发现。